Some 100 years ago, xanthohumol was first isolated and identified. For the last 60 years, scientific research has made remarkable discoveries and gained ever greater insights into its potential as an active agent for health. Throughout the world, numerous universities and research institutes have devoted time and money to investigate the health-enhancing properties of xanthohumol. They have, at this stage, produced an extensive scientific literature on the subject (over 400 papers and articles).
Four commissioned clinical trials substantiate the various health claims arising from these studies. Conducted by the Medical University of Vienna, the Oregon State University, the University Porto as well as the University of South Carolina the clinical trials provided proof positive of XAN Extract’s unrivalled health boosting properties and its outstanding bioavailability.
In addition to lowering blood sugar levels, reducing the incidence of diseases of the cardiovascular- and nervous system or the spread of certain types of cancer, the trials evidenced – and this is a scientific first – DNA protection. Together these properties contribute to a slowing of the aging process. The American clinical studies received FDA sanction.
The most recent research endeavours have demonstrated xanthohumol’s effectiveness in regulating the ability to process sugars and fats. XAN Extract can thus help to significantly reduce blood sugar levels, help combat obesity and diabetes as well as other disorders prevalent in affluent societies.